Ignite Creation Date:
2025-12-25 @ 12:00 AM
Ignite Modification Date:
2026-02-01 @ 10:54 AM
Study NCT ID:
NCT04208958
Status:
COMPLETED
Last Update Posted:
2025-10-27
First Post:
2019-12-16
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of VE800 and Nivolumab in Patients With Selected Types of Advanced or Metastatic Cancer
Sponsor:
Vedanta Biosciences, Inc.
Organization:
Conditions & Keywords Data
Conditions:
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Metastatic Cancer | View |
| None | VE800 | View |
| None | Nivolumab | View |
| None | Opdivo | View |
| None | Melanoma | View |
| None | Gastric Cancer | View |
| None | Gastroesophageal Junction Adenocarcinoma | View |
| None | GEJ Adenocarcinoma | View |
| None | Colorectal Cancer | View |
| None | CRC-MSS | View |
| None | Vedanta | View |
| None | BMS | View |